Who is Stephen Curtis?

Managing Partner at MPM BioImpact

What check size does Stephen Curtis write?

Stephen Curtis typically writes checks of $100K – $5M.

Where did Stephen Curtis go to school?

Stephen Curtis studied at Harvard Medical School (Doctor of Philosophy (Ph.D.), Biological and Biomedical Sciences); Cornell University (Bachelor of Science (B.S.), Molecular and Cellular Biology; Applied Economics and Management).

Stephen Curtis

Investor

Interim VP, Innovation & Impact Investing and Managing Director at BrightEdge

Boston, Massachusetts

Writes $100K – $5M checks · typically $1.5M

Find your path to Stephen

787 people in our graph share verified history with Stephen — schools, employers, funds. One of them is your warm intro.

Mike ZakunlockedStephen: together at Cornell (2001–2006)

×10Stephen: together at Kauffman Fellows

Stephen: together at Cornell

Experience

BrightEdge - American Cancer SocietyInterim VP, Innovation & Impact Investing and Managing Directorcurrent2022 — present
NextPoint Therapeutics, Inc.Strategy / Business Development Consultantcurrent2022 — present
NextPoint Therapeutics, Inc.Interim COO / Board of Directors2019 — 2022Cambridge, Massachusetts, United States
Kauffman FellowsCo-Chair - Boston Chapter2015 — 2022
Kauffman FellowsCo-Chair - Healthcare SIG2015 — 2022
Kauffman FellowsFellow - Class 202015 — 2017
MPM CapitalStealth NewCos - Founding Board Member and COO/CBO2018 — 2022Cambridge, Massachusetts, United States
MPM CapitalManaging Director - Oncology Innovations2018 — 2022Greater Boston Area
MPM CapitalPrincipal2018Greater Boston Area
Dyne TherapeuticsBoard Observer2018 — 2020Cambridge, Massachusetts, United States
Eli Lilly and CompanySr Director, Business Development - Emerging Technology and Innovation2017 — 2018Greater Boston Area
2M Companies, Inc.Bioscience Ventures2014 — 2016Dallas/Fort Worth Area
Reata Pharmaceuticals, Inc.Licensing & Intellectual Property | Biopharmaceutical Leadership Development Program2011 — 2014Irving, TX
Siemens Venture CapitalMarket Analyst Intern2010 — 2011Boston, MA
Laboratory of Dr. Carla Kim, Harvard Medical SchoolDoctoral Student2006 — 2011Boston, MA
Forest Laboratories (now Allergan)Research Assistant2006Commack, NY
Laboratory of Dr. Alexander Nikitin, Cornell UniversityHonors Research Student2002 — 2006Ithaca, NY
The Collaborative Group (now a subdivision of BASF)Research Intern2003Stonybrook, NY

Skills & more

Venture CapitalLife SciencesStart-upsBiotechnologyEntrepreneurshipBusiness DevelopmentBusiness StrategyBiopharmaceuticalsDrug DiscoveryDrug DevelopmentCancerOncology

+3 more

Molecular BiologyImpact InvestingVenture Philanthropy

From Stephen's professional profile.

Colleagues at BrightEdge

Steve Curtis

Managing Director at BrightEdge

Frequently asked questions

Who is Stephen Curtis?: Managing Partner at MPM BioImpact
Where does Stephen Curtis work?: Stephen Curtis is Interim VP, Innovation & Impact Investing and Managing Director at BrightEdge.
What check size does Stephen Curtis write?: Stephen Curtis typically writes checks of $100K – $5M.
Where did Stephen Curtis go to school?: Stephen Curtis studied at Harvard Medical School (Doctor of Philosophy (Ph.D.), Biological and Biomedical Sciences); Cornell University (Bachelor of Science (B.S.), Molecular and Cellular Biology; Applied Economics and Management).

Same school

Also attended Harvard Medical School245

Niko BonatsosFounder and Managing Partner of Verdict Anthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital

+ 239 more

Also attended Cornell University1,165

Jenny LeeSenior Managing Partner at Granite Asia Neeraj AgrawalGeneral Partner at Battery Ventures John ZimmerCo-founder of Lyft Michelle FernandesInvestor at Index Ventures Mike ZakInvestor at CRV (Charles River Ventures)Micah RosenbloomGeneral Partner at Founder Collective

+ 1,159 more

Shared employers

Also worked at Kauffman Fellows406

Jenny LeeSenior Managing Partner at Granite Asia Tobi CokerDeal Partner at Felicis Ventures Roi Bar-KatManaging Director at Intel Capital Avi BharadwajInvestment Director at Intel Capital Nick WashburnSenior Managing Director, Intel Capital (North America)Vinnie LauriaFounding Partner at Golden Gate Ventures

+ 400 more

Also worked at Dyne Therapeutics6

Carlo IncertiOperating Partner at Forbion Jason RhodesPartner at Atlas Venture Sudhir AgrawalInvestor at 82VS Romesh SubramanianVenture Partner at Scion Life Sciences Doug KerrScience Advisor at Exceptional Ventures Phillip SamayoaPrincipal at Atlas Venture

Also worked at Eli Lilly and Company120

David MollerInvestor at Third Rock Ventures Jesper GromadaInvestor at Third Rock Ventures Mark LevinRetired Founding Partner at Third Rock Ventures Natalie FurneyGlobal General Counsel at Takeda Ventures Rhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda Ventures Carlos PayaVenture Partner at Ysios Capital

+ 114 more

Also worked at Reata Pharmaceuticals, Inc.7

Ashley SwerenOperations / Compliance at Standard Crypto Jami TaylorHealthcare Operating Partner at RueOne Investments Jack NielsenManaging Partner at Vivo Capital Sean P. NolanChief Executive Officer and Board Chairman at Taysha Gene Therapies Neil C. ThaparCo-Founder, Board Chairman, CEO & Chief Scientific Officer at Barricade Therapeutics John WallingCo-Founder, SVP, CMC at Barricade Therapeutics

+ 1 more